Hoppa till innehåll
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avancerad
  • Secukinumab provides sustained...
  • Hänvisa
  • Textmeddelande
  • Skicka per e-post
  • Skriv ut
  • Exportera posten
    • Exportera till: RefWorks
    • Exportera till: EndNoteWeb
    • Exportera till: EndNote
  • Permanent länk
Экспорт завершен — 
Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Bibliografiska uppgifter
Huvudupphovsmän: Baraliakos, X, Gossec, L, Pournara, E, Jeka, S, Blanco, R, D'Angelo, S, Schett, G, Schulz, B, Rissler, M, Whyms, D, Perella, C, Coates, LC
Materialtyp: Conference item
Språk:English
Publicerad: Oxford University Press 2021
  • Beståndsuppgifter
  • Beskrivning
  • Liknande verk
  • Katalogiseringsuppgifter

Liknande verk

  • Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
    av: Baraliakos, X, et al.
    Publicerad: (2020)
  • Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
    av: Baraliakos, X, et al.
    Publicerad: (2022)
  • Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
    av: Laure Gossec, et al.
    Publicerad: (2022-07-01)
  • Magnetic resonance imaging characteristics in patients with psoriatic arthritis and axial manifestations from the MAXIMISE cohort
    av: Baraliakos, X, et al.
    Publicerad: (2023)
  • Secukinumab demonstrates high and sustained efficacy in nail psoriasis: Post hoc analysis from phase 3 trials in patients with psoriatic arthritis
    av: Reich, K, et al.
    Publicerad: (2022)

Sökalternativ

  • Sökhistorik
  • Avancerad sökning

Sök mera

  • Bläddra i katalogen
  • Bläddra alfabetiskt
  • Utforska kanaler
  • Kursböcker
  • Nytt i katalogen

Behöver du hjälp?

  • Söktips
  • Fråga biblioteket
  • Vanliga frågor